Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-18

Clinical Trial Update: "THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department" [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating intranasal ketamine vs standard therapy for primary headache disorders in the ED; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal ketamine (ketamine)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Headache, Intranasal Ketamine | Phase 3 | Status: COMPLETED